Table 1 Clinical and pathological characteristics of patient populations
NPT | BPH | HGPIN | PCa | |
|---|---|---|---|---|
Number of patients | 10 | 26 | 37 | 121 |
Age, median (range) | 60 (50–80) | 68 (54–79) | 65 (40–74) | 64 (40–74) |
PSA, ng/mL, median (range) | n.av. | 5.8 (0.8-32.5) | 8.03 (3.35-16.9) | 9.3 (3.1-48.3) |
Gleason score, median (range) | n.a. | n.a. | n.a. | 7 (4–9) |
Pathological stage (%) | ||||
pT2 | n.a. | n.a. | n.a. | 63 (52.1%) |
pT3 | n.a. | n.a. | n.a. | 58 (47.9%) |